Technology · 24/04/2003

Availability for Non-Exclusive, Exclusive, or Partially Exclusive Licensing of U.S. Patent Concerning Monoclonal Antibody Against Ricin A Chain

The U.S. Patent and Trademark Office (USPTO) has made a patent concerning a monoclonal antibody against ricin A chain available for licensing, allowing pharmaceutical companies to obtain exclusive or non-exclusive rights to develop and commercialize the antibody, with the option for partially exclusive licensing in certain circumstances.